Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22149,800,0.98 [0.91-1.05],0.5390855864915833
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22145,128,0.88 [0.75-1.05],0.1603054798511347
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23547,138,1.02 [0.87-1.20],0.7977146531314889
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17560,438,0.95 [0.86-1.04],0.2855168513380857
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23491,82,0.90 [0.73-1.12],0.3525394453546299
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22848,71,0.79 [0.63-1.00],0.0477980660512562
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24379,81,0.92 [0.74-1.14],0.4365079759996881
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24399,55,0.95 [0.74-1.23],0.7126723843052615
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22362,40,1.11 [0.81-1.51],0.5109910691609205
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23939,97,0.90 [0.74-1.09],0.2832323086212711
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23903,61,0.72 [0.57-0.93],0.0101227358899966
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24441,59,1.06 [0.82-1.36],0.6731102212072274
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other viral diseases,24400,92,1.11 [0.90-1.36],0.3239157738411914
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24392,84,1.11 [0.90-1.37],0.3381544964473854
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Mycoses,24233,43,1.10 [0.82-1.48],0.5181976104761135
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23668,339,0.89 [0.80-0.99],0.0345460504014948
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23454,125,0.92 [0.77-1.09],0.3357122627238369
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23549,220,0.89 [0.78-1.02],0.0886730435117426
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",21183,27,0.97 [0.67-1.40],0.8619593916255223
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21200,44,0.94 [0.70-1.26],0.6635396822275104
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21267,111,1.09 [0.91-1.31],0.3618145062114062
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21272,116,nan [nan-nan],
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11897,262,0.93 [0.82-1.05],0.2362167526187604
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9543,22,1.41 [0.92-2.14],0.1108415390318002
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21200,44,0.86 [0.64-1.14],0.2907875905774847
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22594,716,0.99 [0.92-1.07],0.8587499725506478
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23529,179,1.14 [0.98-1.31],0.0830248244719784
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24082,71,0.98 [0.78-1.23],0.86626982918954
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24507,67,1.06 [0.84-1.35],0.605493224617927
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Rectum,24302,39,1.74 [1.27-2.38],0.0006215594322255
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24506,34,1.02 [0.73-1.41],0.925293928842975
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm: Stomach,24544,27,1.05 [0.72-1.51],0.8094812863388134
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm,24274,260,0.94 [0.83-1.05],0.2741600263052275
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24487,107,0.89 [0.74-1.07],0.2233956532387356
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24488,79,0.97 [0.79-1.21],0.8145053758644448
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24459,42,0.77 [0.57-1.03],0.0787019990000078
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,"Haemangioma, any site",24461,42,0.77 [0.57-1.03],0.0786788789477354
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi,24359,212,1.02 [0.90-1.17],0.737564855845088
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24509,96,1.15 [0.95-1.41],0.1609239699011023
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Other benign neoplasms of skin,24422,164,1.00 [0.86-1.16],0.9533148580450042
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Benign neoplasm of breast,13528,82,0.99 [0.80-1.23],0.9336778278339346
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter II Neoplasms,Leiomyoma of uterus,13224,614,1.06 [0.98-1.15],0.1511035950611392
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23671,168,1.02 [0.88-1.19],0.7634647592582067
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23573,308,1.02 [0.91-1.14],0.7423899722036835
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23573,308,1.02 [0.91-1.14],0.7423899722036835
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22477,315,0.94 [0.85-1.05],0.2930766207266648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24104,72,0.94 [0.75-1.18],0.5928044948740032
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24324,87,0.98 [0.80-1.20],0.8277328564601925
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21517,625,1.01 [0.94-1.10],0.7337004298830079
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23426,378,0.98 [0.89-1.09],0.7513261283953108
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22938,91,0.90 [0.73-1.10],0.297180420532394
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Peripheral artery disease,23866,52,0.99 [0.76-1.29],0.9471595740680216
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22926,79,0.90 [0.72-1.12],0.3399904680677349
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,23132,285,1.02 [0.90-1.14],0.7920520594373145
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23125,278,1.02 [0.90-1.15],0.7724714390424293
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22830,154,0.93 [0.78-1.10],0.385181111385092
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22833,151,0.94 [0.79-1.12],0.4930001423233825
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21377,485,0.99 [0.91-1.09],0.8640938142370866
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20959,67,0.87 [0.69-1.10],0.2389867015583803
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,21339,447,0.99 [0.90-1.09],0.816698600508824
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20933,41,1.08 [0.79-1.46],0.6302728669089582
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20955,63,0.90 [0.71-1.15],0.4093733786896294
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Any mental disorder,21283,679,1.00 [0.92-1.08],0.952591949231446
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20872,268,0.99 [0.88-1.12],0.92782161473324
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24168,202,0.99 [0.87-1.14],0.9228185407887516
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24222,147,1.02 [0.87-1.20],0.8273307971462733
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22790,72,0.86 [0.68-1.08],0.1879712542399458
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24448,72,0.85 [0.68-1.07],0.1739227992441306
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20676,72,0.85 [0.68-1.07],0.1639011677786724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Alcohol dependence,22806,88,0.89 [0.72-1.09],0.2587656026948081
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Smoking dependency,22765,64,1.09 [0.85-1.39],0.5123022360156377
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20674,70,0.88 [0.69-1.11],0.2670620793574723
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20942,338,0.99 [0.89-1.10],0.8240933812189214
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Depression,23010,294,0.98 [0.87-1.09],0.673868281755983
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Depression or dysthymia,20816,257,1.02 [0.90-1.16],0.7328467443857927
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20732,128,1.08 [0.91-1.29],0.3553841742043934
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter V Mental and behavioural disorders,Other anxiety disorders,23228,57,0.92 [0.72-1.19],0.5394861584125159
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Neurological diseases,21852,1293,1.02 [0.97-1.08],0.4630057935822699
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20368,160,0.94 [0.80-1.09],0.3968621856103073
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24357,130,0.98 [0.83-1.16],0.8105894893684868
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23371,435,1.03 [0.93-1.13],0.6009774906003149
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Epilepsy,23085,149,0.92 [0.79-1.08],0.3102860167708278
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Migraine,23026,90,1.10 [0.89-1.34],0.3826222947792576
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24218,80,1.11 [0.89-1.37],0.3640214698257016
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Transient ischemic attack,24113,36,1.01 [0.73-1.39],0.9689744405340108
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other sleep disorders,23088,152,1.03 [0.88-1.21],0.6846671763643329
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Sleep apnoea,24003,118,1.03 [0.86-1.23],0.7656634955425274
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23542,540,1.03 [0.95-1.12],0.44661393560051
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23122,120,1.05 [0.88-1.25],0.5815472610222299
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23292,290,1.03 [0.92-1.15],0.6485275709069817
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24356,77,1.13 [0.91-1.41],0.2736185926373559
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Hemiplegia,24329,50,1.13 [0.86-1.49],0.3870281987282834
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Other neurological diseases,24162,109,0.89 [0.74-1.07],0.2173752580397172
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24133,284,1.01 [0.90-1.13],0.8626421834192713
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24002,153,1.01 [0.87-1.19],0.865045049954661
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23930,81,1.02 [0.82-1.26],0.8828844587766772
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23941,92,0.96 [0.79-1.18],0.7259314516241162
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23893,44,1.12 [0.83-1.49],0.4630968069275002
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23022,55,1.21 [0.93-1.57],0.1599704309635187
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23131,164,1.06 [0.91-1.23],0.4508761503962548
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24001,107,1.00 [0.83-1.21],0.961607480221474
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24324,18,1.04 [0.66-1.63],0.8678052864792865
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1547,18,0.95 [0.61-1.46],0.8022209192170211
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22795,18,1.05 [0.67-1.65],0.8385206726567145
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24211,43,1.15 [0.86-1.55],0.3507961334669774
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24191,23,0.96 [0.64-1.43],0.8236480885769875
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24128,84,0.88 [0.72-1.09],0.239877666518432
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24182,91,1.02 [0.83-1.25],0.8736181994172734
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24427,111,0.95 [0.79-1.14],0.6016081443609462
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,24075,85,1.12 [0.90-1.38],0.3050610651411083
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,19156,1744,1.03 [0.98-1.08],0.2942827301023056
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24268,37,0.72 [0.53-0.99],0.0422508240678422
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, essential",20093,1167,1.04 [0.98-1.11],0.1692524522266499
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertension,20109,1183,1.04 [0.98-1.10],0.2395954375661069
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18959,33,0.76 [0.55-1.07],0.113720813149207
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23216,502,0.94 [0.86-1.03],0.1745444640561028
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Angina pectoris,23017,303,0.90 [0.80-1.00],0.0586154008541385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23909,119,0.94 [0.79-1.13],0.5173780268464847
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24016,226,0.92 [0.81-1.04],0.1933780259887251
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24449,51,0.85 [0.65-1.12],0.2481986499630677
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22855,141,0.92 [0.78-1.08],0.2914227251296926
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23081,377,0.95 [0.85-1.05],0.2727207938318728
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Pulmonary embolism,24083,77,1.04 [0.84-1.30],0.7070720746281502
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Venous thromboembolism,24087,159,0.99 [0.85-1.16],0.9244626415164406
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Secondary right heart disease,24067,61,1.05 [0.82-1.35],0.6853881461520529
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24068,62,1.05 [0.82-1.34],0.7003503440239986
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18984,58,1.07 [0.83-1.38],0.6064717474613199
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Cardiomyopathy,22220,40,0.86 [0.64-1.16],0.3281498406662353
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Conduction disorders,22246,66,1.09 [0.86-1.38],0.4776860479753161
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16703,85,1.06 [0.86-1.31],0.589632145499281
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16792,174,1.06 [0.91-1.23],0.4624088078854195
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other arrhythmias,22216,36,1.31 [0.94-1.81],0.1083203314941336
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22234,54,0.91 [0.70-1.18],0.4558033491658532
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Heart failure, strict",24094,109,1.07 [0.89-1.29],0.4597640056628911
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24069,100,1.04 [0.86-1.26],0.695294540589378
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24100,75,1.08 [0.86-1.35],0.5001182168716501
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24142,65,1.04 [0.82-1.33],0.7389597868974677
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23881,45,0.94 [0.71-1.26],0.6870104557738451
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23912,76,0.96 [0.77-1.20],0.7385800566826646
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23470,103,1.05 [0.87-1.27],0.6068003658543588
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,DVT of lower extremities,23453,86,1.08 [0.88-1.34],0.4518427595098047
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24403,83,1.10 [0.89-1.35],0.3973835394800178
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Varicose veins,23753,386,0.84 [0.76-0.92],0.0003715046421951
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,Hypotension,23902,45,0.96 [0.72-1.28],0.7641074318844012
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20768,1727,1.05 [1.00-1.10],0.0671887338155234
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24342,120,1.03 [0.86-1.23],0.7525440509541783
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23496,163,1.06 [0.91-1.24],0.430569860365112
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23473,140,1.06 [0.90-1.25],0.4557903248117351
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23989,196,0.96 [0.83-1.10],0.5466103331997623
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23988,195,0.95 [0.83-1.09],0.4788317524921572
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23758,582,1.04 [0.96-1.13],0.3522727469808637
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic sinusitis,23266,90,1.21 [0.99-1.49],0.0657170398122988
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Nasal polyp,23273,97,1.04 [0.86-1.27],0.6785820461699752
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23548,372,1.04 [0.94-1.15],0.4097156444333939
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Deviated nasal septum,23371,195,1.07 [0.93-1.23],0.3292716856763652
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14100,44,0.95 [0.70-1.27],0.7112753131015352
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22455,783,1.02 [0.95-1.09],0.653540416121211
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Early onset COPD,23910,91,0.93 [0.76-1.14],0.4824064818865593
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23910,91,0.93 [0.76-1.14],0.4824064818865593
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23910,91,0.93 [0.76-1.14],0.4824064818865593
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22981,710,1.01 [0.93-1.08],0.8834192562552321
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Asthma,18756,710,1.01 [0.94-1.09],0.8249532916322605
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18622,710,1.01 [0.94-1.09],0.8293752061407791
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18742,696,1.01 [0.93-1.08],0.879091081559439
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24374,55,1.09 [0.84-1.42],0.4948401596384105
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Interstitial lung disease,23340,41,1.05 [0.78-1.42],0.7318251389293938
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,"ILD, hospital admissions",24432,41,1.06 [0.78-1.43],0.7075475396464851
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23334,35,0.96 [0.70-1.33],0.8060047404101823
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Pleural effusion,23343,69,1.04 [0.82-1.31],0.7702793462613453
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other diseases of pleura,23439,165,1.04 [0.89-1.21],0.6079396384316584
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23795,76,1.10 [0.88-1.38],0.392756643323491
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17425,4562,1.02 [0.99-1.05],0.2644571698493
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24015,437,1.05 [0.95-1.15],0.3344035707138604
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24483,121,0.97 [0.81-1.15],0.7038723850024919
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Impacted teeth,24487,111,0.98 [0.82-1.18],0.835830061360011
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Dental caries,23685,107,1.02 [0.85-1.23],0.8139787126158659
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23676,98,1.10 [0.91-1.34],0.326572538320547
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24471,137,1.00 [0.85-1.18],0.9737864328728008
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23659,81,1.23 [0.99-1.53],0.0608268409305454
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23439,55,0.98 [0.76-1.28],0.9072560357073668
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24435,40,0.86 [0.64-1.17],0.3473189329754774
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19748,185,0.98 [0.85-1.13],0.759215596262237
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21120,1557,1.00 [0.95-1.06],0.9059658467893976
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophagitis,19801,238,1.06 [0.94-1.21],0.3503723646195057
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20061,498,1.00 [0.91-1.09],0.9397397847082242
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19622,59,1.05 [0.81-1.35],0.7251255114432891
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19688,125,1.03 [0.86-1.22],0.7740655874945437
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Oesophageal obstruction,19590,27,1.21 [0.83-1.76],0.3208626690071203
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Gastric ulcer,19655,92,0.99 [0.81-1.21],0.9263531704227288
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Duodenal ulcer,19658,95,0.91 [0.75-1.11],0.3463508090490045
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24453,67,0.89 [0.70-1.12],0.3191116626623517
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Chronic gastritis,19658,95,0.98 [0.80-1.19],0.8165523824314664
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20131,568,1.03 [0.95-1.12],0.4944660931918481
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of appendix,24381,143,0.96 [0.81-1.12],0.5953442738906756
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Functional dyspepsia,19908,345,1.00 [0.90-1.12],0.9346408638096732
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19659,96,0.92 [0.76-1.13],0.4371682609159201
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24372,173,0.96 [0.83-1.11],0.6090929361501634
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute appendicitis,24350,112,0.93 [0.77-1.11],0.4086193730946624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Hernia,22123,1053,1.04 [0.98-1.10],0.2324580202663574
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Inguinal hernia,21422,352,1.05 [0.95-1.17],0.3177119216179439
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Umbilical hernia,21174,104,0.95 [0.79-1.15],0.6266979412046525
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ventral hernia,21151,81,0.85 [0.68-1.05],0.1267978251928686
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21613,543,1.07 [0.98-1.16],0.1243069477401533
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23769,661,1.09 [1.01-1.18],0.0261421964986692
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestines,20215,1469,1.00 [0.95-1.05],0.9138802274473042
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24252,65,0.98 [0.77-1.24],0.8437734918057814
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24472,92,1.10 [0.90-1.35],0.3450262358918385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn disease,23200,92,1.11 [0.91-1.35],0.3188923656299494
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Crohn's disease NAS,23180,72,1.22 [0.97-1.53],0.0902241379925978
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24420,113,1.07 [0.89-1.28],0.4947781482313028
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Ulcerative colitis,23221,113,1.07 [0.89-1.28],0.4663321164407977
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23204,96,1.06 [0.87-1.29],0.5559593148995692
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23640,532,1.11 [1.02-1.21],0.0178108331881055
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23636,528,1.11 [1.02-1.20],0.0197065009829241
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18808,62,1.12 [0.88-1.44],0.3583520286212502
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal stricture,24239,62,1.12 [0.87-1.43],0.3747821332689293
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18790,44,1.09 [0.82-1.47],0.5433052331748678
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19016,270,1.07 [0.95-1.20],0.2869032596367091
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18895,149,1.00 [0.85-1.17],0.9945020495213948
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18969,223,1.12 [0.98-1.28],0.0888255829297125
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Constipation,23528,198,1.12 [0.98-1.29],0.1057779171344374
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of peritoneum,24169,79,1.08 [0.87-1.34],0.4988908850656242
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18907,161,1.00 [0.85-1.16],0.953642581329957
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18831,85,1.01 [0.82-1.24],0.9359961871971932
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19439,693,0.97 [0.90-1.04],0.3668851465875373
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of intestine,18904,158,0.84 [0.72-0.97],0.0221500310900082
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24157,67,1.13 [0.89-1.43],0.3202551883669136
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of liver,23900,109,0.71 [0.59-0.85],0.0001763994981646
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of liver,23853,62,0.74 [0.58-0.94],0.0125691240420271
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23425,459,0.99 [0.90-1.08],0.7579895545626444
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholelithiasis,23332,366,0.97 [0.87-1.07],0.4998511900828575
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Cholecystitis,23033,67,1.00 [0.79-1.27],0.9760386401094776
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23003,37,1.15 [0.84-1.58],0.3912600964370479
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute pancreatitis,23015,49,0.82 [0.62-1.07],0.1431339613977547
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24383,49,0.81 [0.62-1.07],0.1414537296663102
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23431,253,1.08 [0.96-1.22],0.2015410916739767
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Intestinal malabsorption,23239,61,1.04 [0.81-1.34],0.7402921486894383
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Coeliac disease,23227,49,1.01 [0.77-1.33],0.9318568746669594
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23216,38,1.19 [0.87-1.63],0.2866827708789217
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23337,159,1.11 [0.95-1.30],0.1730069172871369
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XI Diseases of the digestive system,GI-bleeding,23332,154,1.10 [0.94-1.28],0.2536420375157342
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22258,1304,0.98 [0.93-1.04],0.5615884456816957
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24203,90,1.00 [0.81-1.22],0.9678525309406192
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24171,414,1.00 [0.91-1.10],0.953935629142176
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23559,456,0.96 [0.88-1.06],0.438094083585141
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23845,359,1.01 [0.91-1.12],0.8022364254830336
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23580,94,0.92 [0.75-1.12],0.3998942781663466
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23690,204,1.02 [0.89-1.17],0.8034608932283244
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24315,76,0.95 [0.77-1.19],0.6770556099030165
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24302,63,1.02 [0.80-1.30],0.8902120393605724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24285,46,0.98 [0.74-1.30],0.8729848644235748
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24402,28,nan [nan-nan],
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24399,25,0.97 [0.66-1.42],0.8682119860763694
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23815,58,1.17 [0.91-1.51],0.2201548012414593
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24071,314,1.00 [0.90-1.11],0.9918962832165884
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23160,57,0.95 [0.74-1.23],0.6955330528810109
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23189,86,0.90 [0.73-1.11],0.317408576182674
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23175,72,0.90 [0.72-1.13],0.3661173163296378
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23280,177,0.97 [0.84-1.12],0.6916240480696465
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23258,155,0.91 [0.78-1.07],0.2446687980856899
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18987,3109,1.00 [0.97-1.04],0.8345869093418099
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20400,1657,1.00 [0.95-1.05],0.8575857999231765
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22371,974,1.09 [1.02-1.16],0.010228279891965
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18857,114,1.03 [0.86-1.23],0.7609371277449569
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19055,312,1.00 [0.89-1.11],0.95714548474945
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24247,109,1.04 [0.86-1.25],0.6993905903307984
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24259,97,1.01 [0.83-1.23],0.9094098443094304
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19334,591,1.03 [0.95-1.11],0.5290975190225806
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21600,591,1.03 [0.95-1.12],0.5059678194926851
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18784,41,1.16 [0.86-1.58],0.3232630170588569
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24210,40,1.15 [0.85-1.56],0.370983518533903
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18875,132,0.94 [0.79-1.11],0.4400889976480542
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18765,22,1.07 [0.71-1.61],0.7464783438445457
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18855,112,1.04 [0.87-1.25],0.6510537386954015
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24441,57,1.00 [0.78-1.29],0.996568413512204
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19040,297,1.06 [0.94-1.18],0.3552401629881951
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18941,198,1.00 [0.87-1.15],0.9880680589195338
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19835,1092,0.98 [0.93-1.05],0.6073604094252489
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18780,37,1.06 [0.77-1.45],0.739318961760447
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18899,156,0.90 [0.77-1.05],0.1748312282712665
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18767,24,1.06 [0.72-1.58],0.7558106989865484
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18769,26,0.97 [0.66-1.42],0.8749036205388652
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19201,458,1.04 [0.95-1.14],0.4206827448093184
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19125,382,1.04 [0.94-1.15],0.3995901359053169
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19371,245,0.99 [0.88-1.13],0.924561862199586
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24182,146,0.87 [0.74-1.02],0.0787279901150856
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24073,37,0.73 [0.53-1.00],0.0495474762671899
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21921,45,0.92 [0.69-1.23],0.5629924981758727
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22075,199,0.91 [0.79-1.04],0.159819868017556
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22677,801,0.94 [0.88-1.01],0.0903741212557156
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22000,124,1.04 [0.88-1.24],0.6263516966091456
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21925,49,0.74 [0.56-0.97],0.0294762320083193
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22549,673,0.95 [0.88-1.03],0.1931054190157926
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21927,51,0.92 [0.71-1.21],0.5622358544127329
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22099,223,0.99 [0.87-1.12],0.827986037882571
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21973,97,1.02 [0.84-1.25],0.8188284508971371
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21937,61,0.95 [0.74-1.22],0.6786528379469133
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22001,125,0.93 [0.78-1.11],0.4278525346458558
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21937,61,1.09 [0.85-1.40],0.5042955916814789
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22165,289,1.00 [0.89-1.12],0.9707857924582056
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21646,249,1.01 [0.89-1.14],0.8921778971888078
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21445,48,1.00 [0.76-1.33],0.9745637957264166
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21440,43,1.00 [0.74-1.34],0.9790467596071096
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21501,104,1.06 [0.87-1.28],0.5656594274829088
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21449,52,1.16 [0.89-1.52],0.2797156091778592
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21453,56,1.41 [1.08-1.83],0.0104725671388099
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21439,42,1.29 [0.95-1.75],0.0977118728041093
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21587,190,1.00 [0.87-1.15],0.9827685903560166
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21444,47,1.04 [0.78-1.38],0.779604729796209
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21442,45,1.02 [0.77-1.37],0.8711592270761563
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21490,93,1.03 [0.85-1.26],0.7454823435401362
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21462,65,0.99 [0.78-1.26],0.917314822877194
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21787,390,1.13 [1.02-1.25],0.0182672862888571
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21533,136,1.06 [0.90-1.26],0.4678436318758879
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21599,202,1.22 [1.07-1.40],0.0042143447674836
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23285,93,0.99 [0.81-1.22],0.9522726002843452
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23492,300,0.95 [0.85-1.07],0.3958966413645395
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23241,49,1.03 [0.78-1.35],0.8493664599014984
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23249,57,1.01 [0.78-1.30],0.9341020843079648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23295,103,0.95 [0.79-1.15],0.6010740979085731
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20775,3850,0.96 [0.93-1.00],0.0372249587534764
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9964,353,1.01 [0.91-1.12],0.8112455796554902
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23222,163,0.85 [0.73-0.98],0.0310440156273361
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23105,46,1.11 [0.83-1.48],0.469962014007767
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Acute renal failure,23369,33,0.56 [0.40-0.78],0.0006174301570032
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23366,30,0.78 [0.55-1.11],0.1672558649507665
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23375,39,0.83 [0.61-1.13],0.2367287378022351
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urolithiasis,24222,206,0.98 [0.85-1.12],0.7157427334544076
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24288,48,1.01 [0.76-1.33],0.9644359874194596
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24159,143,0.98 [0.83-1.15],0.8200539983233714
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24100,84,1.07 [0.87-1.32],0.5250389561650025
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23192,778,0.95 [0.89-1.02],0.1784402188908547
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Cystitis,22485,71,0.85 [0.68-1.07],0.1679200624208564
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22472,58,1.08 [0.84-1.39],0.5592668373824817
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22574,160,1.01 [0.87-1.18],0.8934345595020642
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Urethral stricture,22496,82,1.01 [0.82-1.25],0.9299307714125458
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22958,544,0.96 [0.89-1.05],0.3940576015575507
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9674,63,1.21 [0.95-1.55],0.1236671419012325
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9644,33,0.84 [0.60-1.17],0.3012609309181007
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Hydrocele,9645,34,0.95 [0.68-1.32],0.7520874864828541
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9683,72,1.04 [0.83-1.30],0.7293448171020154
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9668,57,1.19 [0.92-1.54],0.1833902352253067
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9695,84,0.89 [0.72-1.10],0.2699710016233556
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Disorders of breast,13404,219,1.03 [0.90-1.17],0.682273842422696
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13251,66,1.12 [0.88-1.43],0.3417969899734431
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13258,73,1.03 [0.82-1.29],0.8209275917064046
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13234,49,0.93 [0.71-1.23],0.6243405702466442
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13368,337,1.00 [0.90-1.11],0.9914382308924232
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,13101,70,0.99 [0.79-1.25],0.9298482758217648
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13200,169,1.02 [0.88-1.19],0.7770850813114002
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12328,2429,1.02 [0.97-1.06],0.4589650018492949
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Endometriosis,10156,257,1.11 [0.98-1.26],0.1052721705187434
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9981,82,1.29 [1.03-1.61],0.0244579902192009
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),10001,102,1.09 [0.90-1.33],0.3811761728918548
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10170,271,1.07 [0.95-1.21],0.2682949924279898
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10166,267,0.90 [0.80-1.02],0.0900229247240458
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10316,417,1.01 [0.91-1.11],0.9176749040174956
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Uterine polyps,10043,144,0.95 [0.80-1.11],0.4959537728668939
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10090,191,1.14 [0.99-1.32],0.0695880602490145
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9972,73,1.14 [0.91-1.44],0.2518220917138837
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,10026,127,1.09 [0.92-1.30],0.3262135978984022
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13537,179,1.11 [0.96-1.28],0.1774327629352418
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13545,172,1.11 [0.95-1.29],0.1880970064373996
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13560,99,1.14 [0.94-1.39],0.1928792329611595
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13553,107,1.13 [0.94-1.37],0.1967921992917496
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9960,61,0.86 [0.67-1.09],0.2142620216662332
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9953,54,1.02 [0.78-1.33],0.9034547338648024
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9962,63,0.82 [0.64-1.05],0.1096246523108616
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Irregular menses,13470,329,1.12 [1.00-1.25],0.0469032808986328
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10904,1005,1.06 [1.00-1.13],0.0673463442538859
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Menorrhagia,10588,689,1.03 [0.96-1.11],0.4304382913191122
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13545,141,1.03 [0.87-1.21],0.736256177970815
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10209,310,0.98 [0.88-1.10],0.7412999546332514
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,10129,230,0.96 [0.84-1.10],0.5561354591360521
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10128,229,1.08 [0.95-1.23],0.2430183297406787
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,Female infertility,9987,88,1.13 [0.91-1.40],0.2787659479213656
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9980,81,1.10 [0.88-1.37],0.4119671991880725
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13553,733,1.01 [0.93-1.09],0.8115620482373531
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13560,1014,1.04 [0.96-1.11],0.3321234030886376
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13555,394,1.12 [1.01-1.24],0.031314236688702
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13272,111,1.14 [0.95-1.38],0.164256521745391
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13317,156,1.03 [0.88-1.22],0.6773964685147252
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13301,140,1.25 [1.05-1.48],0.0131137833109016
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13570,143,1.00 [0.85-1.18],0.9788684448466264
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13572,140,1.00 [0.85-1.19],0.965125780098313
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13569,364,0.95 [0.86-1.06],0.3888972731864385
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13312,107,0.86 [0.71-1.04],0.1145342616730782
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13408,203,0.95 [0.83-1.10],0.5140413320565724
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12945,125,1.09 [0.91-1.30],0.3684174332644196
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12992,172,0.98 [0.84-1.14],0.7816538690259452
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,13023,203,0.97 [0.84-1.11],0.6236095192206088
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12942,122,1.05 [0.87-1.25],0.6294429597958257
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",False labour,12935,115,1.07 [0.89-1.29],0.4843131478264002
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12946,126,0.95 [0.80-1.14],0.5971176084160121
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12738,192,1.11 [0.96-1.29],0.1533810214190833
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12925,379,1.00 [0.90-1.11],0.996608882296224
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,13108,562,1.06 [0.97-1.16],0.2201059771405488
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13575,147,1.05 [0.89-1.24],0.5597661262437235
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12347,113,1.03 [0.85-1.24],0.7540816628570954
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12631,85,0.99 [0.80-1.22],0.9024952099085624
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13580,289,0.98 [0.87-1.10],0.6948733765592172
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13514,223,0.95 [0.83-1.09],0.4996300091742633
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13569,216,1.02 [0.89-1.17],0.7544512290372757
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2","Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13559,206,1.03 [0.89-1.18],0.7316846747034441
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24328,32,0.93 [0.66-1.30],0.6569018720291906
PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",Chapter VI Diseases of the nervous system,Falls/tendency to fall,23081,451,0.90 [0.82-0.99],0.0266647628110297
